Biosims Technologies Overview

  • Founded
  • 2010

Founded
  • Status
  • Out of Business

  • Employees
  • 11

Employees
  • Latest Deal Type
  • Liquidation

Biosims Technologies General Information

Description

Developer and manufacturer of high-performance analytical tools for life science industries. The company's Dynaxi detection platform, its software and kits allows extremely low amounts of targets in a sample to be monitored, at a level never reached so far on a chip device.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Primary Office
  • Seine biopolis II
  • 75, Route de Lyons la forêt
  • 76000 Rouen
  • France
+33 09 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosims Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 27-Dec-2016 00.000 Completed Bankruptcy: Liquidation
4. Early Stage VC 22-May-2015 00.000 00.000 Completed Startup
3. Early Stage VC 12-Dec-2013 Completed Startup
2. Debt - General Completed Startup
1. Grant Completed Startup
To view Biosims Technologies’s complete valuation and funding history, request access »

Biosims Technologies Patents

Biosims Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3023792-A1 Spot control Withdrawn 18-Nov-2014 00000000000 0
EP-2478372-A1 Improved method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) Granted 15-Sep-2009 00000000000
US-20120172249-A1 Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) Abandoned 15-Sep-2009 00000000000
CA-2774125-A1 Improved method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) Abandoned 15-Sep-2009 00000000000
EP-2478372-B1 Improved method and array for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) Not-In-Force 15-Sep-2009 G01N33/6848
To view Biosims Technologies’s complete patent history, request access »

Biosims Technologies Executive Team (5)

Name Title Board Seat Contact Info
Christine Heuclin Chief Executive Officer & Co-Founder
Jean Belouard Sales Manager & European Sales Director
Guillaume Legent Ph.D Co-Founder & Senior Scientist
You’re viewing 3 of 5 executive team members. Get the full list »

Biosims Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial